Pyridoxal-5-Phosphate

Preferred form for those with impaired B6 conversion. Well-supported for mood, homocysteine reduction, and neurotransmitter synthesis.

A rough internal score reflecting quantity, quality, and consistency of human evidence. Not a clinical recommendation.

B6 is well-established as essential for neurotransmitter synthesis, homocysteine metabolism, and immune function. P5P form is preferred for individuals with liver impairment or genetic polymorphisms affecting conversion.

• Active form requires no hepatic conversion
• Supports neurotransmitter synthesis
• Helps lower homocysteine levels
• Essential for amino acid metabolism

25–100 mg daily. RDA for B6 is 1.3–2.0 mg; higher therapeutic doses used under guidance.

• Generally well tolerated
• Vivid dreams at higher doses
• Neuropathy risk much lower than with pyridoxine

High-dose pyridoxine (not P5P) has caused peripheral neuropathy. P5P appears safer but prudent to keep doses reasonable.

For most people, standard pyridoxine is adequate. P5P primarily benefits those with conversion issues.

• Mood55
• Energy45
• Focus40